Liddle J, Beneton V, Benson M, Bingham R, et al. A potent and selective Kallikrein-5 inhibitor delivers high pharmacological activity in Netherton Syndrome patient skin. J Invest Dermatol 2021 Mar 17. pii: S0022-202X(21)00994.
PMID: 33744298